Bimodal virological response to antiretroviral therapy for HIV infection: An application using a mixture model with left censoring

Xiuhong Li, Haitao Chu, Joel E. Gallant, Donald R. Hoover, Wendy J. Mack, Joan S. Chmiel, Alvaro Munoz

Research output: Contribution to journalArticle

Abstract

Study objective: To assess whether HIV RNA levels (log10 scale) in highly active antiretroviral therapy (HAART) treated population have a bimodal distribution, suggesting optimal or suboptimal response to HAART. Methods: The study population from two ongoing cohort studies comprised 564 men (4785 person visits) and 1173 women (8675 person visits) with known dates of HAART initiation and with HIV RNA measurements before and after initiation. Values below detection limit of assays were treated in the analysis as left censored. Maximum likelihood methods were used to estimate parameters and to determine possible bimodality of HIV RNA distributions. Results: A two component mixture model fitted HIV RNA levels significantly better than did a single component distribution at different years from HAART initiation in both therapy experienced and therapy naive patients. In the fifth year after HAART initiation, 32% of men and 44% of women had HIV RNA in the higher component with medians of 5247 and 9253 copies/ml, respectively, suggesting suboptimal virological response to HAART, which was associated with poor adherence and lower frequency of CCR5 heterozygous genotype. Conclusion: The bimodal distribution of HIV RNA persisted during the years after HAART initiation. The high occurrence of suboptimal virological response at the fifth year after HAART initiation underscore the needs for careful monitoring and patient education about the importance of treatment adherence. This data analysis overcomes limitations of measurement techniques of observations having values below detection limits and serves to characterise the dynamics of the virological response to therapies.

Original languageEnglish (US)
Pages (from-to)811-818
Number of pages8
JournalJournal of Epidemiology and Community Health
Volume60
Issue number9
DOIs
StatePublished - Sep 2006

Fingerprint

Highly Active Antiretroviral Therapy
HIV Infections
HIV
RNA
Therapeutics
Limit of Detection
Patient Education
Population
Cohort Studies
Genotype

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Bimodal virological response to antiretroviral therapy for HIV infection : An application using a mixture model with left censoring. / Li, Xiuhong; Chu, Haitao; Gallant, Joel E.; Hoover, Donald R.; Mack, Wendy J.; Chmiel, Joan S.; Munoz, Alvaro.

In: Journal of Epidemiology and Community Health, Vol. 60, No. 9, 09.2006, p. 811-818.

Research output: Contribution to journalArticle

Li, Xiuhong ; Chu, Haitao ; Gallant, Joel E. ; Hoover, Donald R. ; Mack, Wendy J. ; Chmiel, Joan S. ; Munoz, Alvaro. / Bimodal virological response to antiretroviral therapy for HIV infection : An application using a mixture model with left censoring. In: Journal of Epidemiology and Community Health. 2006 ; Vol. 60, No. 9. pp. 811-818.
@article{1d4a93309d41457faaa0af8111e1192a,
title = "Bimodal virological response to antiretroviral therapy for HIV infection: An application using a mixture model with left censoring",
abstract = "Study objective: To assess whether HIV RNA levels (log10 scale) in highly active antiretroviral therapy (HAART) treated population have a bimodal distribution, suggesting optimal or suboptimal response to HAART. Methods: The study population from two ongoing cohort studies comprised 564 men (4785 person visits) and 1173 women (8675 person visits) with known dates of HAART initiation and with HIV RNA measurements before and after initiation. Values below detection limit of assays were treated in the analysis as left censored. Maximum likelihood methods were used to estimate parameters and to determine possible bimodality of HIV RNA distributions. Results: A two component mixture model fitted HIV RNA levels significantly better than did a single component distribution at different years from HAART initiation in both therapy experienced and therapy naive patients. In the fifth year after HAART initiation, 32{\%} of men and 44{\%} of women had HIV RNA in the higher component with medians of 5247 and 9253 copies/ml, respectively, suggesting suboptimal virological response to HAART, which was associated with poor adherence and lower frequency of CCR5 heterozygous genotype. Conclusion: The bimodal distribution of HIV RNA persisted during the years after HAART initiation. The high occurrence of suboptimal virological response at the fifth year after HAART initiation underscore the needs for careful monitoring and patient education about the importance of treatment adherence. This data analysis overcomes limitations of measurement techniques of observations having values below detection limits and serves to characterise the dynamics of the virological response to therapies.",
author = "Xiuhong Li and Haitao Chu and Gallant, {Joel E.} and Hoover, {Donald R.} and Mack, {Wendy J.} and Chmiel, {Joan S.} and Alvaro Munoz",
year = "2006",
month = "9",
doi = "10.1136/jech.2005.044644",
language = "English (US)",
volume = "60",
pages = "811--818",
journal = "Journal of Epidemiology and Community Health",
issn = "0143-005X",
publisher = "BMJ Publishing Group",
number = "9",

}

TY - JOUR

T1 - Bimodal virological response to antiretroviral therapy for HIV infection

T2 - An application using a mixture model with left censoring

AU - Li, Xiuhong

AU - Chu, Haitao

AU - Gallant, Joel E.

AU - Hoover, Donald R.

AU - Mack, Wendy J.

AU - Chmiel, Joan S.

AU - Munoz, Alvaro

PY - 2006/9

Y1 - 2006/9

N2 - Study objective: To assess whether HIV RNA levels (log10 scale) in highly active antiretroviral therapy (HAART) treated population have a bimodal distribution, suggesting optimal or suboptimal response to HAART. Methods: The study population from two ongoing cohort studies comprised 564 men (4785 person visits) and 1173 women (8675 person visits) with known dates of HAART initiation and with HIV RNA measurements before and after initiation. Values below detection limit of assays were treated in the analysis as left censored. Maximum likelihood methods were used to estimate parameters and to determine possible bimodality of HIV RNA distributions. Results: A two component mixture model fitted HIV RNA levels significantly better than did a single component distribution at different years from HAART initiation in both therapy experienced and therapy naive patients. In the fifth year after HAART initiation, 32% of men and 44% of women had HIV RNA in the higher component with medians of 5247 and 9253 copies/ml, respectively, suggesting suboptimal virological response to HAART, which was associated with poor adherence and lower frequency of CCR5 heterozygous genotype. Conclusion: The bimodal distribution of HIV RNA persisted during the years after HAART initiation. The high occurrence of suboptimal virological response at the fifth year after HAART initiation underscore the needs for careful monitoring and patient education about the importance of treatment adherence. This data analysis overcomes limitations of measurement techniques of observations having values below detection limits and serves to characterise the dynamics of the virological response to therapies.

AB - Study objective: To assess whether HIV RNA levels (log10 scale) in highly active antiretroviral therapy (HAART) treated population have a bimodal distribution, suggesting optimal or suboptimal response to HAART. Methods: The study population from two ongoing cohort studies comprised 564 men (4785 person visits) and 1173 women (8675 person visits) with known dates of HAART initiation and with HIV RNA measurements before and after initiation. Values below detection limit of assays were treated in the analysis as left censored. Maximum likelihood methods were used to estimate parameters and to determine possible bimodality of HIV RNA distributions. Results: A two component mixture model fitted HIV RNA levels significantly better than did a single component distribution at different years from HAART initiation in both therapy experienced and therapy naive patients. In the fifth year after HAART initiation, 32% of men and 44% of women had HIV RNA in the higher component with medians of 5247 and 9253 copies/ml, respectively, suggesting suboptimal virological response to HAART, which was associated with poor adherence and lower frequency of CCR5 heterozygous genotype. Conclusion: The bimodal distribution of HIV RNA persisted during the years after HAART initiation. The high occurrence of suboptimal virological response at the fifth year after HAART initiation underscore the needs for careful monitoring and patient education about the importance of treatment adherence. This data analysis overcomes limitations of measurement techniques of observations having values below detection limits and serves to characterise the dynamics of the virological response to therapies.

UR - http://www.scopus.com/inward/record.url?scp=33748088512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748088512&partnerID=8YFLogxK

U2 - 10.1136/jech.2005.044644

DO - 10.1136/jech.2005.044644

M3 - Article

C2 - 16905728

AN - SCOPUS:33748088512

VL - 60

SP - 811

EP - 818

JO - Journal of Epidemiology and Community Health

JF - Journal of Epidemiology and Community Health

SN - 0143-005X

IS - 9

ER -